Search - tctmd.com

Displaying 161 - 180 of 184

Sort: Relevancy | Date

Alirocumab Ban Reversed, New Trial Ordered in PCSK9 Patent Dispute

News Daily News

Alirocumab Ban Reversed, New Trial Ordered in PCSK9 Patent Dispute

Michael O'Riordan

October 10, 2017

Ankur Kalra, MD

News Featured Fellow

Ankur Kalra, MD

Yael L. Maxwell

May 26, 2017

ACC 2017: CVD Outcomes for Evolocumab, Intermediate-Risk TAVR, Coronary Physiology Tests, and More

News Conference News ACC 2017

ACC 2017: CVD Outcomes for Evolocumab, Intermediate-Risk TAVR, Coronary Physiology Tests, and More

March 10, 2017

Updated AUC for Stable Ischemic Heart Disease Seek to Match ‘Appropriateness’ to Current Practice

News Daily News

Updated AUC for Stable Ischemic Heart Disease Seek to Match ‘Appropriateness’ to Current Practice

March 10, 2017

‘Inappropriate’ PCI: New York State Efforts Appear to Make a Dent

News Daily News

‘Inappropriate’ PCI: New York State Efforts Appear to Make a Dent

March 07, 2017

Conflicting Results: Personal Financial Ties Among Investigators Linked to Positive Trial Findings

News Daily News

Conflicting Results: Personal Financial Ties Among Investigators Linked to Positive Trial Findings

January 19, 2017

News Daily News

‘Appropriate’ Use of Revascularization in ACS: Updated Criteria Released at Last

December 21, 2016

News Daily News

Improved Adherence to Medical Therapy Reduces CVD Events in Secondary Prevention Patients

Michael O'Riordan

August 16, 2016

News Conference News EuroPCR 2016

From Italy to Bangladesh: STEMI Networks Matter

May 18, 2016

News Daily News

导管室并发症：新的分析精准确定了 ACS 患者术中血栓事件的事件率及风险

January 21, 2016

News Daily News

Complicaciones en el Laboratorio de Cateterización: Un Nuevo Análisis Define el Índice y Riesgos de los Episodios Trombóticos Intraoperatorios en el Manejo del SCA

January 21, 2016

News Daily News

Cath-Lab Complications: New Analysis Pinpoints Rate and Risks of Intraprocedural Thrombotic Events in ACS

January 21, 2016

News Industry News

New Analyses from the IMPROVE-IT Outcomes Study of VYTORIN® (ezetimibe and simvastatin) and the TECOS Cardiovascular Safety Trial of JANUVIA® Will Be Presented at the European Society of Cardiology

August 20, 2015

News Features

Opportunities Exist for Hospitals, Interventionalists to Stave Off Unnecessary Readmissions

July 28, 2015

News Industry News

Micell Technologies Announces First Patient Enrolled in Registration Trial of MiStent SES in China

July 22, 2015

News Daily News

En Análisis ACCOAST Identifica los Factores asociados a Más Riesgos Hemorrágicos en el Manejo de Cuadros de SCASEST

June 22, 2015

News Daily News

ACCOAST分析发现了NSTE-ACS患者更高出血风险的有关因素

June 22, 2015

News Daily News

ACCOAST Analysis Identifies Factors Tied to Higher Bleeding Risks in NSTE-ACS

June 22, 2015

News Industry News

First CVD Outcome Trial of a GLP-1 Agonist Finds No Cardiac Risk or Benefit

June 09, 2015

News Daily News

心力衰竭会使ACS后的结果恶化，阿哌沙班不能带来益处

January 28, 2015

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.